Por un programa nacional de colecta y criopreservación de células de sangre de cordón en Cuba

Rivero Jiménez, René A.
Rev. cuba. hematol. inmunol. hemoter ; 33(1): 1-19, ene.-mar. 2017. ilus, tab
Artículo en Español | LILACS, CUMED | ID: biblio-901072

Documentos relacionados

  1. Total nucleated cell counts are driving clinician's choice rather than cryopreservation period: Lesson for cord blood banks.
  2. Long-Term Stability of Cord Blood Units After 29 Years of Cryopreservation: Follow-Up Data From the José Carreras Cord Blood Bank.
  3. Current thawing and infusion practice of cryopreserved cord blood: the impact on graft quality, recipient safety, and transplantation outcomes.
  4. Using umbilical cord blood for regenerative therapy: Proof or promise?
  5. Umbilical cord blood: The promise and the uncertainty.
  6. Cryopreserved CD34<sup>+</sup> Cell Dose, but Not Total Nucleated Cell Dose, Influences Hematopoietic Recovery and Extensive Chronic Graft-versus-Host Disease after Single-Unit Cord Blood Transplantation in Adult Patients.
  7. [Recent advances in cord blood stem cell transplantation].
  8. Cord blood transplants: one, two or more units?
  9. Dominant unit CD34+ cell dose predicts engraftment after double-unit cord blood transplantation and is influenced by bank practice.
  10. Current practices for viability testing of cryopreserved cord blood products: an international survey by the cellular therapy team of the Biomedical Excellence for Safer Transfusion (BEST) Collaborative.